MTIM
CVIIW

Marathon Trading Investment Management’s Churchill Capital Corp VII Warrants CVIIW Stock Holding History

Marathon Trading Investment Management’s Portfolio CVIIW Stock Details CVIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,412
Closed -$7.14K – 359
2024
Q2 		$7.14K Hold
20,412
– – ﹤0.01% 273
2024
Q1 		$6.53K Hold
20,412
– – ﹤0.01% 332
2023
Q4 		$3.27K Hold
20,412
– – ﹤0.01% 351
2023
Q3 		$6.29K Hold
20,412
– – ﹤0.01% 304
2023
Q2 		$2.86K Hold
20,412
– – ﹤0.01% 253
2023
Q1 		$2.5K Hold
20,412
– – ﹤0.01% 256
2022
Q4 		$1.01K Hold
20,412
– – ﹤0.01% 272
2022
Q3 		$3K Hold
20,412
– – ﹤0.01% 272
2022
Q2 		$7K Hold
20,412
– – ﹤0.01% 277
2022
Q1 		$12K Hold
20,412
– – ﹤0.01% 306
2021
Q4 		$20K Hold
20,412
– – ﹤0.01% 293
2021
Q3 		$19K Buy
+20,412
New +$22.8K ﹤0.01% 364

Marathon Trading Investment Management's CVIIW Position: Q3 2024 in Review

Marathon Trading Investment Management sold out of Churchill Capital Corp VII Warrants (CVIIW) in Q3 2024, closing a stake of 20,412 shares — an estimated $7.14K sold.

Marathon Trading Investment Management first reported a position in CVIIW in Q3 2021 and held it in 12 quarters. The position peaked at $20K in Q4 2021. 0 funds tracked by Wall St. Rank hold CVIIW as of Q3 2024.

  • Marathon Trading Investment Management reported no remaining Churchill Capital Corp VII Warrants position as of Q3 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 20,412 Churchill Capital Corp VII Warrants shares in Q3 2024, an estimated $7.14K.
  • Marathon Trading Investment Management first reported a position in Churchill Capital Corp VII Warrants in Q3 2021 and held it in 12 quarters.
  • Marathon Trading Investment Management's Churchill Capital Corp VII Warrants position peaked at $20K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Churchill Capital Corp VII Warrants as of Q3 2024.

Based on Marathon Trading Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.